The latest profit margin for RADLY is 2.99% as of June 2026. That compares with 2.98% in the prior-year period — up 0.1% year over year. That is below the Healthcare sector average of 13.89%. Investors often review this figure alongside Raia Drogasil S.A.'s historical trend and sector peers before judging valuation or financial health.

Over the past year, RADLY's profit margin moved from 2.98% to 2.99% — a 0.1% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Raia Drogasil S.A.'s valuation or profitability profile.

Against Healthcare companies, RADLY currently prints 2.99% for profit margin, while the sector average sits near 13.89%. That is roughly 78.5% below the sector mean. Large gaps often invite a closer look at Raia Drogasil S.A.'s growth, margins, and balance sheet.

Profit Margin shows how effectively Raia Drogasil S.A. converts resources into returns. At 2.99%, RADLY may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with 2.98% in the prior-year period — up 0.1% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting RADLY's profit margin (2.99%), review year-over-year change from 2.98%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.